vimarsana.com

Page 3 - மையம் மருத்துவமனையாளர் யுனிவர்சிட்டேர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Covid update: 04 February 2021

Covid update: 04 February 2021 04 Feb 2021 A round up of this week s coronavirus-related news and countermeasures from the photonics industry. Icovid was set up in March, 2020, by UZ Brussel, KU Leuven, icometrix and ETRO, an imec research group of VUB. Professor Jef Vandemeulebroucke of ETRO commented, “What started as a local project is now being rolled out in 800 hospitals in Europe and supported by excellent research centers all over Europe. “With icolung, we can detect Covid-19 patients at an early stage and quantify the extent of lung lesions. Meanwhile, we are further improving the AI software to identify lung damage from Covid-19 even more quickly, and to determine the further care path of the patient faster and better through prognostic models.”

Icovid rolled out across Europe

Icovid rolled out across Europe Icovid, which was set up in March by UZ Brussel, KU Leuven, icometrix, VUB and Imec is now being rolled out in 800 hospitals in Europe and supported by research centres all over Europe. “With icolung, we can detect COVID-19 patients at an early stage and quantify the extent of lung lesions,” says Professor Jef Vandemeulebroucke of ETRO, “meanwhile, we are further improving the AI software to identify lung damage from COVID-19 even more quickly, and to determine the further care path of the patient faster and better through prognostic models.” The icovid project was launched in March 2020 as a Belgian pro bono initiative. Icometrix, which specializes in AI solutions for medical images, partnered with UZ Brussel, KU Leuven, VUB and imec to investigate how to deploy lung scans in the COVID pandemic and what AI software would be needed to do so. The AI tool icolung was born.

Biomodex Teams Up with Physicians at Three of the World s Top Medical Centers to Develop a Cutting-Edge Training Solution for Treatment of Ischemic Stroke

Share this article Share this article BOSTON, Feb. 1, 2021 /PRNewswire/  BIOMODEX®, a pioneering digital health company that offers a unique and enhanced 3D printed solution for physician training, announced today the company has partnered with two of the top medical centers in France and a world-class health system in the United States to develop EVIAS Plus ™ – an innovative training solution for treatment of ischemic stroke. Ischemic stroke accounts for about 87 percent of all strokes in the U.S. according to the American Stroke Society. This type of stroke is a medical emergency that occurs when a clot forms inside a vessel supplying blood to the brain, where aspiration and mechanical thrombectomy are common treatments. These procedures involve inserting a catheter into an artery in the arm or groin and moving it towards the blood clot under X-ray guidance. The clot may be removed by trapping it in a stent-retriever (mechanical), by sucking out the clot through the cat

Belgian initiative for AI lung scan analysis in fight against COVID-19 goes European

Share this article Share this article LEUVEN, Belgium, Jan. 26, 2021 /PRNewswire/ The Belgian initiative icovid, which supports radiologists in the assessment of CT images of the lungs of COVID-19 patients, has grown into a multicentre European project, co-funded by the EU Horizon 2020 programme. icovid was set up in March by UZ Brussel, KU Leuven, ico metrix and ETRO, an imec research group of VUB. Professor Jef Vandemeulebroucke of ETRO: What started as a local project is now being rolled out in 800 hospitals in Europe and supported by excellent research centres all over Europe. With ico lung, we can detect COVID-19 patients at an early stage and quantify the extent of lung lesions. Meanwhile, we are further improving the AI software to identify lung damage as COVID-19 even more quickly, and to determine the further care path of the patient faster and better through prognostic models.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.